{"count": 23, "results": [{"_id": "36147344", "pmid": 36147344, "pmcid": "PMC9486097", "title": "Literature review of the clinical characteristics of metformin-induced hepatotoxicity", "journal": "Front Pharmacol", "authors": ["Wang C", "Deng H", "Xu Y", "Liu Y"], "date": "2022-09-06T00:00:00Z", "doi": "10.3389/fphar.2022.969505", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "969505", "score": 50279.848, "text_hl": "Literature review of the clinical characteristics of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-induced hepatotoxicity", "citations": {"NLM": "Wang C, Deng H, Xu Y, Liu Y. Literature review of the clinical characteristics of metformin-induced hepatotoxicity Front Pharmacol. 2022;13():969505. PMID: 36147344", "BibTeX": "@article{36147344, title={Literature review of the clinical characteristics of metformin-induced hepatotoxicity}, author={Wang C and Deng H and Xu Y and Liu Y}, journal={Front Pharmacol}, volume={13}, pages={969505}}"}}, {"_id": "33151165", "pmid": 33151165, "title": "Efficacy and safety of the metformin-mazindol anorectic combination in rat.", "journal": "Acta Pharm", "authors": ["Argüelles-Tello F", "Roa-Coria JE", "Zúñiga-Romero Á", "Huerta-Cruz JC", "Quiñonez-Bastidas GN", "Flores-Murrieta FJ", "Rocha-González HI", "Reyes-García JG"], "date": "2021-06-01T00:00:00Z", "doi": "10.2478/acph-2021-0019", "meta_date_publication": "2021 Jun 1", "meta_volume": "71", "meta_issue": "2", "meta_pages": "279-291", "score": 50252.64, "text_hl": "Theoretical effective dose 40 (ED40t) did not differ from the experimental effective dose 40 (ED40e) obtained with the @CHEMICAL_Mazindol @CHEMICAL_MESH:D008454 @@@mazindol@@@-@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ mixture in the @<m>DISEASE_Anorexia</m> @DISEASE_MESH:D000855 @@@anorexia@@@ experiments, by Student's t-test. ", "citations": {"NLM": "Argüelles-Tello F, Roa-Coria JE, Zúñiga-Romero Á, Huerta-Cruz JC, Quiñonez-Bastidas GN, Flores-Murrieta FJ, Rocha-González HI, Reyes-García JG. Efficacy and safety of the metformin-mazindol anorectic combination in rat. Acta Pharm. 2021 Jun 1;71(2):279-291. PMID: 33151165", "BibTeX": "@article{33151165, title={Efficacy and safety of the metformin-mazindol anorectic combination in rat.}, author={Argüelles-Tello F and Roa-Coria JE and Zúñiga-Romero Á and Huerta-Cruz JC and Quiñonez-Bastidas GN and Flores-Murrieta FJ and Rocha-González HI and Reyes-García JG}, journal={Acta Pharm}, volume={71}, number={2}, pages={279-291}}"}}, {"_id": "36001956", "pmid": 36001956, "title": "The GDF15-GFRAL pathway is dispensable for the effects of metformin on energy balance.", "journal": "Cell Rep", "authors": ["Klein AB", "Nicolaisen TS", "Johann K", "Fritzen AM", "Mathiesen CV", "Gil C", "Pilmark NS", "Karstoft K", "Blond MB", "Quist JS", "Seeley RJ", "Færch K", "Lund J", "Kleinert M", "Clemmensen C"], "date": "2022-08-23T00:00:00Z", "doi": "10.1016/j.celrep.2022.111258", "meta_date_publication": "2022 Aug 23", "meta_volume": "40", "meta_issue": "8", "meta_pages": "111258", "score": 50251.84, "text_hl": "The data presented here question whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is a sufficiently strong stimulator of @GENE_GDF15 @GENE_9518 @@@GDF15@@@ to drive @<m>DISEASE_Anorexia</m> @DISEASE_MESH:D000855 @@@anorexia@@@ and @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight loss@@@ and emphasize that additional work is needed to untangle the relationship among @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @GENE_GDF15 @GENE_9518 @@@GDF15@@@, and energy balance.", "citations": {"NLM": "Klein AB, Nicolaisen TS, Johann K, Fritzen AM, Mathiesen CV, Gil C, Pilmark NS, Karstoft K, Blond MB, Quist JS, Seeley RJ, Færch K, Lund J, Kleinert M, Clemmensen C. The GDF15-GFRAL pathway is dispensable for the effects of metformin on energy balance. Cell Rep. 2022 Aug 23;40(8):111258. PMID: 36001956", "BibTeX": "@article{36001956, title={The GDF15-GFRAL pathway is dispensable for the effects of metformin on energy balance.}, author={Klein AB and Nicolaisen TS and Johann K and Fritzen AM and Mathiesen CV and Gil C and Pilmark NS and Karstoft K and Blond MB and Quist JS and Seeley RJ and Færch K and Lund J and Kleinert M and Clemmensen C}, journal={Cell Rep}, volume={40}, number={8}, pages={111258}}"}}, {"_id": "31769886", "pmid": 31769886, "title": "Comparison of gastrointestinal adverse events with different doses of metformin in the treatment of elderly people with type 2 diabetes.", "journal": "J Clin Pharm Ther", "authors": ["Yuxin H", "Cuiping J", "Wen T", "Jieyuzhen Q", "Xiaoming T", "Qin G", "Haidong W", "Jiao S", "Zhijun B"], "date": "2020-06-01T00:00:00Z", "doi": "10.1111/jcpt.13087", "meta_date_publication": "2020 Jun", "meta_volume": "45", "meta_issue": "3", "meta_pages": "470-476", "score": 50244.277, "text_hl": "METHODS: A total of 361 elderly @SPECIES_9606 @@@patients@@@ with newly diagnosed @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ were randomly divided into three groups: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ 1000 mg/d (N = 120), @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ 1500 mg/d (N = 121) and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ 2000 mg/d (N = 120). ", "citations": {"NLM": "Yuxin H, Cuiping J, Wen T, Jieyuzhen Q, Xiaoming T, Qin G, Haidong W, Jiao S, Zhijun B. Comparison of gastrointestinal adverse events with different doses of metformin in the treatment of elderly people with type 2 diabetes. J Clin Pharm Ther. 2020 Jun;45(3):470-476. PMID: 31769886", "BibTeX": "@article{31769886, title={Comparison of gastrointestinal adverse events with different doses of metformin in the treatment of elderly people with type 2 diabetes.}, author={Yuxin H and Cuiping J and Wen T and Jieyuzhen Q and Xiaoming T and Qin G and Haidong W and Jiao S and Zhijun B}, journal={J Clin Pharm Ther}, volume={45}, number={3}, pages={470-476}}"}}, {"_id": "39787747", "pmid": 39787747, "title": "A phase I study of temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer.", "journal": "Gynecol Oncol", "authors": ["Ahmed J", "Stephen B", "Khawaja MR", "Yang Y", "Salih I", "Barrientos-Toro E", "Raso MG", "Karp DD", "Piha-Paul SA", "Sood AK", "Ng CS", "Johnson A", "Soliman PT", "Meric-Bernstam F", "Lu KH", "Naing A"], "date": "2025-01-08T00:00:00Z", "doi": "10.1016/j.ygyno.2024.12.019", "meta_date_publication": "2025 Jan 8", "meta_volume": "193", "meta_issue": "", "meta_pages": "73-80", "score": 50244.223, "text_hl": "In addition to inducing metabolic changes in cells, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ activates @GENE_PRKAA2 @GENE_5563 @@@AMPK@@@, which in turn inhibits the @GENE_MTOR @GENE_2475 @@@mTOR@@@ pathway. ", "citations": {"NLM": "Ahmed J, Stephen B, Khawaja MR, Yang Y, Salih I, Barrientos-Toro E, Raso MG, Karp DD, Piha-Paul SA, Sood AK, Ng CS, Johnson A, Soliman PT, Meric-Bernstam F, Lu KH, Naing A. A phase I study of temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer. Gynecol Oncol. 2025 Jan 8;193():73-80. PMID: 39787747", "BibTeX": "@article{39787747, title={A phase I study of temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer.}, author={Ahmed J and Stephen B and Khawaja MR and Yang Y and Salih I and Barrientos-Toro E and Raso MG and Karp DD and Piha-Paul SA and Sood AK and Ng CS and Johnson A and Soliman PT and Meric-Bernstam F and Lu KH and Naing A}, journal={Gynecol Oncol}, volume={193}, pages={73-80}}"}}, {"_id": "34251983", "pmid": 34251983, "title": "Management of type 2 diabetes mellitus in older adults: eight case studies with focus SGLT-2 inhibitors and metformin.", "journal": "Acta Clin Belg", "authors": ["Bahat G", "Catikkas NM", "Karan MA", "Petrovic M"], "date": "2022-08-01T00:00:00Z", "doi": "10.1080/17843286.2021.1952379", "meta_date_publication": "2022 Aug", "meta_volume": "77", "meta_issue": "4", "meta_pages": "727-734", "score": 50243.953, "text_hl": "We aimed to outline our experience with three oldest-old @SPECIES_9606 @@@patients@@@ with high cardiovascular risk managed with SGLT-2 inhibitors, and five @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Anorexia</m> @DISEASE_MESH:D000855 @@@anorexia@@@/@DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight loss@@@ managed by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ cessation. ", "citations": {"NLM": "Bahat G, Catikkas NM, Karan MA, Petrovic M. Management of type 2 diabetes mellitus in older adults: eight case studies with focus SGLT-2 inhibitors and metformin. Acta Clin Belg. 2022 Aug;77(4):727-734. PMID: 34251983", "BibTeX": "@article{34251983, title={Management of type 2 diabetes mellitus in older adults: eight case studies with focus SGLT-2 inhibitors and metformin.}, author={Bahat G and Catikkas NM and Karan MA and Petrovic M}, journal={Acta Clin Belg}, volume={77}, number={4}, pages={727-734}}"}}, {"_id": "36464072", "pmid": 36464072, "title": "[Cross-Sectional Study on Adverse Effects of Metformin Hydrochloride on 130 Patients Type 2 Diabetic Admitted to Medical Center and Diabetes Home of Sidi Bel-Abbes].", "journal": "Ann Pharm Fr", "authors": ["Sakouhi M", "Matmour D", "Belakhdar K", "Kraroubi A"], "date": "2022-12-02T00:00:00Z", "doi": "10.1016/j.pharma.2022.11.013", "meta_date_publication": "2022 Dec 2", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50236.605, "text_hl": "Five (3.85%) @SPECIES_9606 @@@patients@@@ had a total and lasting intolerance to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MetforminHydrochloride@@@ leading to its discontinuation following persistent @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhoea@@@. ", "citations": {"NLM": "Sakouhi M, Matmour D, Belakhdar K, Kraroubi A. [Cross-Sectional Study on Adverse Effects of Metformin Hydrochloride on 130 Patients Type 2 Diabetic Admitted to Medical Center and Diabetes Home of Sidi Bel-Abbes]. Ann Pharm Fr. 2022 Dec 2;():. PMID: 36464072", "BibTeX": "@article{36464072, title={[Cross-Sectional Study on Adverse Effects of Metformin Hydrochloride on 130 Patients Type 2 Diabetic Admitted to Medical Center and Diabetes Home of Sidi Bel-Abbes].}, author={Sakouhi M and Matmour D and Belakhdar K and Kraroubi A}, journal={Ann Pharm Fr}}"}}, {"_id": "32855828", "pmid": 32855828, "pmcid": "PMC7443033", "title": "A Case of Diabetic Ketoacidosis in a Patient on an SGLT2 Inhibitor and a Ketogenic Diet: A Critical Trio Not to Be Missed", "journal": "Case Rep Endocrinol", "authors": ["Steinmetz-Wood S", "Gilbert M", "Menson K"], "date": "2020-08-13T00:00:00Z", "doi": "10.1155/2020/8832833", "meta_date_publication": "2020", "meta_volume": "2020", "meta_issue": "", "meta_pages": "8832833", "score": 50234.793, "text_hl": "A 47-year-old male with a history of poorly controlled T2DM on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_empagliflozin @CHEMICAL_MESH:C570240 @@@empagliflozin@@@ presented to the emergency department (ED) with several days of @DISEASE_Pharyngitis @DISEASE_MESH:D010612 @@@pharyngitis@@@, @DISEASE_Dyspnea @DISEASE_MESH:D004417 @@@dyspnea@@@, @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@emesis@@@, @DISEASE_Abdominal_Pain @DISEASE_MESH:D015746 @@@abdominal pain@@@, and @<m>DISEASE_Anorexia</m> @DISEASE_MESH:D000855 @@@anorexia@@@. ", "citations": {"NLM": "Steinmetz-Wood S, Gilbert M, Menson K. A Case of Diabetic Ketoacidosis in a Patient on an SGLT2 Inhibitor and a Ketogenic Diet: A Critical Trio Not to Be Missed Case Rep Endocrinol. 2020;2020():8832833. PMID: 32855828", "BibTeX": "@article{32855828, title={A Case of Diabetic Ketoacidosis in a Patient on an SGLT2 Inhibitor and a Ketogenic Diet: A Critical Trio Not to Be Missed}, author={Steinmetz-Wood S and Gilbert M and Menson K}, journal={Case Rep Endocrinol}, volume={2020}, pages={8832833}}"}}, {"_id": "22950061", "pmid": 22950061, "pmcid": "PMC3428418", "title": "Intracerebroventricular Injection of Metformin Induces Anorexia in Rats", "journal": "Diabetes Metab J", "authors": ["Lee CK", "Choi YJ", "Park SY", "Kim JY", "Won KC", "Kim YW"], "date": "2012-08-01T00:00:00Z", "doi": "10.4093/dmj.2012.36.4.293", "meta_date_publication": "2012 Aug", "meta_volume": "36", "meta_issue": "4", "meta_pages": "293-9", "score": 50085.652, "text_hl": "Intracerebroventricular Injection of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Induces @<m>DISEASE_Anorexia</m> @DISEASE_MESH:D000855 @@@Anorexia@@@ in Rats", "citations": {"NLM": "Lee CK, Choi YJ, Park SY, Kim JY, Won KC, Kim YW. Intracerebroventricular Injection of Metformin Induces Anorexia in Rats Diabetes Metab J. 2012 Aug;36(4):293-9. PMID: 22950061", "BibTeX": "@article{22950061, title={Intracerebroventricular Injection of Metformin Induces Anorexia in Rats}, author={Lee CK and Choi YJ and Park SY and Kim JY and Won KC and Kim YW}, journal={Diabetes Metab J}, volume={36}, number={4}, pages={293-9}}"}}, {"_id": "12806790", "pmid": 12806790, "title": "Metformin induced anorexia and weight loss.", "journal": "Hawaii Med J", "authors": ["Wong LL", "Wong TC"], "date": "2003-05-01T00:00:00Z", "meta_date_publication": "2003 May", "meta_volume": "62", "meta_issue": "5", "meta_pages": "104-5", "score": 50082.734, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ induced @<m>DISEASE_Anorexia</m> @DISEASE_MESH:D000855 @@@anorexia@@@ and @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight loss@@@.", "citations": {"NLM": "Wong LL, Wong TC. Metformin induced anorexia and weight loss. Hawaii Med J. 2003 May;62(5):104-5. PMID: 12806790", "BibTeX": "@article{12806790, title={Metformin induced anorexia and weight loss.}, author={Wong LL and Wong TC}, journal={Hawaii Med J}, volume={62}, number={5}, pages={104-5}}"}}]}